Rainbow Children’s Medicare Limited (RCML) has announced its unaudited financial results for the third quarter and first nine months of FY26, ending December 31, 2025. The company reported a steady Q3 performance with improvements across key performance indicators (KPIs). Operationally, the quarter saw an increase in outpatient footfalls, inpatient discharges, and deliveries. New units demonstrated strengthened performance, reflecting the gradual progress of bed additions over the past year. RCML expanded its footprint with the commissioning of a 100-bed hospital in Rajahmundry, Andhra Pradesh, and a ~90-bed hospital in Electronic City, Bengaluru. With planned capacity additions for the current cycle largely complete, RCML is shifting its focus to execution, prioritizing strengthening operations, improving occupancies, enhancing the service mix, and building sustainable volumes. The appointment of Mr. Abrar ali Dalal as Chief Executive Officer is highlighted as a key step in this transition. Financially, for Q3 FY26, Revenue stood at ₹445.4 crore (INR 4,454 Mn), an 11.9% year-on-year increase from ₹398.1 crore (INR 3,981 Mn) in Q3 FY25. EBITDA was ₹147 crore (INR 1,470 Mn), up 9.4% YoY. Profit After Tax (PAT) was ₹73.9 crore (INR 739 Mn), a 7.2% increase YoY. For the nine months ended December 31, 2025, Revenue reached ₹1,243.2 crore (INR 12,432 Mn), an 8.5% increase from ₹1,145.8 crore (INR 11,458 Mn) in the same period last year. EBITDA for 9M FY26 was ₹399.5 crore (INR 3,995 Mn), up 6.5% YoY, and PAT was ₹203.3 crore (INR 2,033 Mn), up 8.3% YoY. Operational highlights include an 18% increase in Capacity Beds to 2,285 and a 15% increase in Operational Beds to 1,758. Occupancy rates were 47.19% in Q3 FY26, a decrease from 53.20% in Q3 FY25. Inpatient Discharges increased by 9% YoY to 27,977, and Outpatient Consultations saw an 18% rise to 4,17,342. Key developments include the successful integration of hospitals in Guwahati, Warangal, and Rajahmundry. The Hennur facility is nearing completion, and construction is progressing for hospitals in Coimbatore, Gurugram, and Pune, with the latter two targeted for FY27 completion. The company maintains a robust balance sheet with cash and cash equivalents totaling ₹579.2 crore (Rs. 5,792 Mn) as of December 31, 2025, sufficient for ongoing capital expenditures and M&A plans.
